Manx Financial Group PLC Issue of Shares pursuant to the Scrip Dividend

RNS Number : 1009T

Manx Financial Group PLC

19 June 2024

 

FOR IMMEDIATE RELEASE                                            19 June 2024

 

 

Manx Financial Group PLC (the "Company")

 

Issue of Ordinary Shares pursuant to the Scrip Dividend

and Total Voting Rights

 

Further to the notification made on 24 May 2024 in relation to the Scrip Dividend, the Company announces that it has received valid elections from shareholders resulting in a requirement to issue 1,013,821 New Ordinary Shares ("New Shares") at a price of 19.0 pence per share.

 

Jim Mellon and Dr Gregory Bailey, both Directors and significant shareholders of the Company, have elected to be issued 391,160 and 324,153 Ordinary Shares of no par value ("Ordinary Shares") respectively at a price of 19.00 pence per share representing their partial Script Dividend entitlements, thus maintaining their joint percentage holding under the Concert Party whitewash waiver approved on 9 April 2020. Douglas Grant and Alan Clarke, also Directors of the Company, have elected to receive Ordinary Shares under the Scrip Dividend as further set out in the table below.

 

Application has been made for the total of 1,013,821 New Shares to satisfy the Scrip Dividend exercise, which will rank pari passu with all existing Ordinary Shares, to be admitted to trading on AIM. Admission is expected on or around 25 June 2024.

 

Following the issue of the New Shares and Additional Allotment, the Company's issued share capital consists of 117,555,757 Ordinary Shares of no-par value, with voting rights ("Ordinary Shares"). The Company does not hold any Ordinary Shares in Treasury. Therefore, the total number of Ordinary Shares in the Company with voting rights is 117,555,757.

 

Directors' Dealings

 

The respective holdings of the Directors following the issue of ordinary shares pursuant to the Scrip Dividend:

 

	Scrip Shares Issued	Total number of shares held	% of Issued Capital
Jim Mellon 1	391,160	22,139,374	18.83%
Gregory Bailey 2	324,153	18,346,827	15.61%
Douglas Grant 3	29,775	1,272,904	1.08%
Alan Clarke	1,341	55,994	0.05%

 

¹     Burnbrae Limited holds 19,811,392 Ordinary Shares. Burnbrae Limited is 100% beneficially owned by Jim Mellon. Denham Eke, Executive Vice-Chairman of MFG, is also a director of Burnbrae Limited. Vidacos Nominees Limited also holds 2,327,982 Ordinary Shares in trust for Jim Mellon.

²     Vidacos Nominees Limited holds 18,346,827 Ordinary Shares in trust for Gregory Bailey.

³     Douglas Grant holds 556,138 Ordinary Shares in his own name and 716,766 Ordinary shares in his SIPP.

 

Total Voting Rights

 

The figure of 117,555,757 Ordinary Shares may be used by shareholders in the Company from the date of admission as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the shares of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU No. 596/2014) AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN AND SUCH PERSONS SHALL THEREFORE CEASE TO BE IN POSSESSION OF INSIDE INFORMATION.

 

For further information, please contact:

 

Manx Financial Group PLC Denham Eke, Executive Vice Chairman Tel [phone]

Beaumont Cornish Limited Roland Cornish/James Biddle Tel [phone]

Greentarget Limited Jamie Brownlee Tel: [phone]

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

MSCGPUGWQUPCGWB